Research progress on direct-acting antiviral agents(DAAs)in treatment of hepatitis C / 中华临床感染病杂志
Chinese Journal of Clinical Infectious Diseases
;
(6): 8-13, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-514554
ABSTRACT
In recent years,great progress has been made in treatment of patients with HCV infection with direct-acting antiviral agents (DAAs).Up to now,twelve kinds of oral DAAs and three kinds of combination regimens have been approved by the U.S.Food and Drug Administration and European Medicines Agency to treat chronic HCV infection.This article reviews the research progress of DAAs in treatment of hepatitis C,including the name of DAAs,drug targets,therapy regimen,clinical efficacy and adverse effects.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Clinical Infectious Diseases
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS